Loading...
XSHE002524
Market cap265mUSD
Dec 26, Last price  
3.79CNY
1D
-0.26%
1Q
-1.04%
Jan 2017
-64.38%
IPO
-55.14%
Name

Guangzheng Eye Hospital Group Co Ltd

Chart & Performance

D1W1MN
XSHE:002524 chart
P/E
209.42
P/S
1.80
EPS
0.02
Div Yield, %
0.00%
Shrs. gr., 5y
-1.49%
Rev. gr., 5y
-1.77%
Revenues
1.07b
+40.06%
154,168,254237,693,237276,034,688381,737,396426,429,261465,811,149505,428,670626,305,185555,185,320499,295,990553,994,8791,175,291,8321,284,867,050921,048,6031,044,476,897767,444,6051,074,903,561
Net income
9m
11,872,45522,367,00619,087,16122,296,22124,343,58027,875,1151,549,70306,497,2804,841,8855,416,3880157,111,23932,097,23536,927,24209,255,045
CFO
44m
-64.90%
5,430,5465,213,05610,535,1270025,031,63211,929,98895,280,411133,121,44567,428,894121,351,679321,050,56879,045,976154,988,066145,374,912124,329,57543,636,441
Dividend
May 28, 20130.025 CNY/sh
Earnings
May 20, 2025

Profile

Guangzheng Eye Hospital Group Co., Ltd. provides ophthalmic medical services in China. It invests in and manages ophthalmic hospitals. The company opeates13 eye hospitals and 1 optometry clinic in Shanghai, Chengdu, Chongqing, Zhengzhou, Nanchang, Hohhot, Jinan, Qingdao, Wuxi, Yiwu, etc. In addition, it is involved in the design, manufacture, installation, and after-sales service of light steel, heavy steel, multi-high-rise stee, and space and long-span steel structures, as well as construction of steel bridges and systems. Further, the company is engaged in natural gas transportation and operation of gas filling stations. Guangzheng Eye Hospital Group Co., Ltd. was founded in 2001 and is headquartered in Urumqi, the People's Republic of China.
URL
http://www.gzykcn.com/
IPO date
Dec 17, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,074,904
40.06%
767,445
-26.52%
1,044,477
13.40%
Cost of revenue
845,188
752,698
954,096
Unusual Expense (Income)
NOPBT
229,716
14,747
90,381
NOPBT Margin
21.37%
1.92%
8.65%
Operating Taxes
(1,833)
2,222
8,492
Tax Rate
15.06%
9.40%
NOPAT
231,549
12,525
81,889
Net income
9,255
 
36,927
15.05%
Dividends
Dividend yield
Proceeds from repurchase of equity
(12,278)
(3,060)
BB yield
0.41%
0.09%
Debt
Debt current
263,596
360,823
288,992
Long-term debt
911,117
897,276
981,491
Deferred revenue
1
1
30,000
Other long-term liabilities
13,248
18,509
(30,000)
Net debt
1,064,512
1,098,697
1,173,968
Cash flow
Cash from operating activities
43,636
124,330
145,375
CAPEX
(23,424)
Cash from investing activities
(14,348)
1,244
Cash from financing activities
(13,930)
(11,755)
FCF
275,479
(97,835)
(284,342)
Balance
Cash
91,062
65,410
89,324
Long term investments
19,138
93,992
7,191
Excess cash
56,455
121,030
44,291
Stockholders' equity
255,940
563,603
533,804
Invested Capital
1,000,140
971,068
1,076,661
ROIC
23.49%
1.22%
9.71%
ROCE
21.73%
1.35%
8.05%
EV
Common stock shares outstanding
462,752
501,766
533,358
Price
6.45
-9.66%
7.14
-22.14%
9.17
-36.14%
Market cap
2,984,752
-16.69%
3,582,608
-26.75%
4,890,895
-32.53%
EV
4,051,909
4,683,024
6,065,694
EBITDA
330,049
114,762
196,772
EV/EBITDA
12.28
40.81
30.83
Interest
14,504
36,336
37,715
Interest/NOPBT
6.31%
246.40%
41.73%